Pre-Approval Information Exchange (PIE) Sessions

What is a PIE Session?

It’s an opportunity for pharmaceutical companies to share clinical and access information on medications awaiting approval through Pre-Approval Information Exchange (PIE) with pharmacists who meet the criteria of Health Care Decision Makers (HCDMs). The focus of these exchanges is to provide HCDMs with critical data for proactive planning on new cancer drugs before market approval.
These events occur in conjunction with the ATOPP Summit. There are two types of PIE Sessions: Live and Virtual.

ATOPP Live PIE Sessions

What:

Live events taking place at ATOPP Summit

When:

  • Session 1:
    Syndax: Presenting Revumenib
    July 11, 2025
    10:30 – 11:15am MT
    Grand Ballroom A
  • Session 2:
    AstraZeneca and Daiichi-Sankyo: Presenting Fam-trastuzumab deruxtecan-nxki (T-DXd): DESTINY-Breast09
    July 11, 2025
    10:30 – 11:15am MT
    Grand Ballroom Reception A
  • Session 3:
    Amneal: Unlocking Value in Oncology Care: Delivering Access Through Amneal’s upcoming Biosimilar and 505(b)(2) launches
    July 11, 2025
    1:30 – 2:15pm MT
    Grand Ballroom Reception A
  • Session 4:
    Sobi: Presenting avatrombopag (Doptelet) pediatric ITP
    July 11, 2025
    1:30 – 2:15pm MT
    Grand Ballroom A

Where:

The ATOPP Summit
Grand America Hotel
555 Main Street
Salt Lake City, UT 84111

ATOPP Virtual PIE Sessions

What:

Virtual events taking place after the ATOPP Summit


When:

  • Jazz Pharmaceuticals – July 23, 2025 – ZOOM link for registration here!
  • Daiichi-Sankyo – October 2025 (exact date TBD)

Where:

ZOOM Webinar Platform

FOR INDUSTRY

Are you hosting a PIE Session?

Hear from Dave Hughes, Senior Medical Director – Hematology at Pfizer, on what a PIE session is and the value from an industry perspective, as a pharmaceutical company hosting the event:

Apply to host a PIE Session (Join the waitlist)

FOR HCDMs

Are you wanting to attend a PIE Session?

Hear from Kristen Boykin, Director of Pharmacy Operations at Florida Cancer Specialists & Research Institute, on what to expect at a PIE Session as a Health Care Decision Maker (HCDM):

Register to attend a live PIE Session (for HCDMs)

What is a HCDM?

You may be a HCDM if you are a:
  • Member of a formulary committee OR provide information to a committee that selects drugs to include on formulary or within treatment pathways (eg, P&T committee)
  • Member of a committee OR provide information to a committee that makes decisions regarding drug selection, formulary inclusion, coverage, reimbursement, clinical pathways, healthcare quality, patient outcomes, or contracting for health care organizations (e.g., integrated delivery networks, hospitals, health systems, GPOs).
  • Formulary decision maker for a payer by providing information for the purpose of making formulary decisions.
Pharmaceutical companies will conduct four concurrent 45-minute PIE sessions in private rooms, exclusively for pharmacist attendees meeting the sponsor’s HCDM criteria.
No employees from a competing pharmaceutical company are permitted to attend PIE sessions. A networking refreshment break will be available at this time for anyone who is not permitted to attend the PIE sessions.

CE Synergy, LLC | Site by Big Picture Digital | Privacy Policy | Cookie Policy | Terms & Conditions | Careers |